ADAR1 Capital Management, LLC
Insider CIK 1940272 · PIRS 10% owner · NXTC 10% owner · KROS 10% owner · INM 10% owner · RLYB 10% owner · TENX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NXTC NextCure, Inc. | P Buy | 2026-10-27 | 2026-10-27 | 3,553 | $5.10 | $18.1K | 733,270 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-10-26 | 2026-10-27 | 1,672 | $5.03 | $8.4K | 729,717 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-10-23 | 2026-10-27 | 5,626 | $4.83 | $27.2K | 728,045 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-23 | 2026-10-27 | 4 | $1.32 | $5 | 956,584 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-10-21 | 2026-10-21 | 331,979 | $1.66 | $550.7K | 7,447,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-10-20 | 2026-10-21 | 254,342 | $1.60 | $405.7K | 7,115,021 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-19 | 2026-10-20 | 1,086 | $1.32 | $1.4K | 956,580 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-10-19 | 2026-10-21 | 336,528 | $1.51 | $507.0K | 6,860,679 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-16 | 2026-10-20 | 1 | $1.32 | $1 | 955,494 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-15 | 2026-10-15 | 984 | $1.32 | $1.3K | 955,493 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-14 | 2026-10-15 | 8,021 | $1.33 | $10.7K | 954,509 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-13 | 2026-10-15 | 564 | $1.33 | $750 | 946,488 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-08 | 2026-10-08 | 2,256 | $1.33 | $3.0K | 945,924 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-07 | 2026-10-08 | 3,046 | $1.33 | $4.1K | 943,668 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-06 | 2026-10-08 | 5,601 | $1.33 | $7.4K | 940,622 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-05 | 2026-10-05 | 18,182 | $1.33 | $24.2K | 935,021 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-02 | 2026-10-05 | 8,307 | $1.33 | $11.0K | 916,839 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-10-01 | 2026-10-05 | 16,431 | $1.33 | $21.8K | 908,532 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-09-16 | 2026-09-16 | 8,340 | $1.29 | $10.8K | 892,101 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-09-16 | 2026-09-16 | 8,340 | $1.29 | $10.8K | 892,101 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-09-15 | 2026-09-16 | 54,256 | $1.30 | $70.5K | 883,761 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-09-15 | 2026-09-16 | 54,256 | $1.30 | $70.4K | 883,761 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-09-14 | 2026-09-16 | 28,505 | $1.29 | $36.8K | 829,505 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-09-14 | 2026-09-16 | 28,505 | $1.29 | $36.9K | 829,505 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-09-03 | 2026-09-08 | 900,000 | $1.78 | $1.60M | 6,524,151 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-09-03 | 2026-09-08 | 900,000 | $1.78 | $1.60M | 6,524,151 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-09-02 | 2026-09-02 | 187,704 | $1.80 | $337.9K | 5,624,151 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-09-02 | 2026-09-02 | 187,704 | $1.80 | $337.6K | 5,624,151 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-09-01 | 2026-09-02 | 179,058 | $1.80 | $322.3K | 5,436,447 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-09-01 | 2026-09-02 | 179,058 | $1.80 | $321.6K | 5,436,447 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-08-31 | 2026-09-02 | 403,571 | $1.79 | $722.4K | 5,257,389 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-08-31 | 2026-09-02 | 403,571 | $1.79 | $722.6K | 5,257,389 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-08-24 | 2026-08-24 | 107,374 | $1.75 | $187.9K | 4,853,818 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-08-24 | 2026-08-24 | 107,374 | $1.75 | $188.4K | 4,853,818 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-08-21 | 2026-08-24 | 716,369 | $1.77 | $1.27M | 4,746,444 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-08-21 | 2026-08-24 | 716,369 | $1.77 | $1.27M | 4,746,444 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-08-20 | 2026-08-24 | 202,124 | $1.78 | $359.8K | 4,030,075 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2026-08-20 | 2026-08-24 | 202,124 | $1.78 | $359.5K | 4,030,075 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-31 | 2026-08-03 | 25,000 | $4.98 | $124.5K | 714,416 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-31 | 2026-08-03 | 3,300 | $4.98 | $16.4K | 689,416 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-31 | 2026-08-03 | 8,003 | $4.80 | $38.4K | 722,419 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-31 | 2026-08-03 | 8,003 | $4.80 | $38.4K | 722,419 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-31 | 2026-08-03 | 25,000 | $4.98 | $124.5K | 714,416 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-31 | 2026-08-03 | 3,300 | $4.98 | $16.4K | 689,416 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 100,000 | $4.90 | $490.0K | 608,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 77,850 | $4.96 | $386.1K | 686,116 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 25,000 | $4.81 | $120.2K | 508,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 20,000 | $5.00 | $100.0K | 483,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 20,000 | $5.00 | $100.0K | 463,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 50,000 | $4.97 | $248.5K | 443,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 77,850 | $4.96 | $385.8K | 686,116 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 100,000 | $4.90 | $490.0K | 608,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 25,000 | $4.81 | $120.3K | 508,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 20,000 | $5.00 | $100.0K | 483,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 20,000 | $5.00 | $100.0K | 463,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-30 | 2026-08-03 | 50,000 | $4.97 | $248.6K | 443,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-29 | 2026-07-29 | 1,600 | $5.00 | $8.0K | 393,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-29 | 2026-07-29 | 1,810 | $5.00 | $9.1K | 391,666 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-29 | 2026-07-29 | 1,600 | $5.00 | $8.0K | 393,266 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-29 | 2026-07-29 | 1,810 | $5.00 | $9.1K | 391,666 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-28 | 2026-07-29 | 6,400 | $4.95 | $31.7K | 389,856 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-28 | 2026-07-29 | 6,400 | $4.95 | $31.7K | 389,856 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-27 | 2026-07-29 | 7,798 | $5.00 | $39.0K | 383,456 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2026-07-27 | 2026-07-29 | 7,798 | $5.00 | $39.0K | 383,456 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-15 | 2026-07-17 | 1,000 | $1.56 | $1.6K | 801,000 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-19 | 2026-05-20 | 200 | $13.80 | $2.8K | 926,352 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-19 | 2026-05-20 | 10,000 | $13.98 | $139.8K | 926,152 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-05-19 | 2026-05-21 | 200,000 | $1.50 | $300.0K | 800,000 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-05-19 | 2026-05-21 | 200,000 | $1.56 | $312.0K | 600,000 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-05-19 | 2026-05-21 | 68,551 | $1.60 | $109.7K | 400,000 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-18 | 2026-05-20 | 6,009 | $13.98 | $84.0K | 916,152 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-15 | 2026-05-15 | 100 | $13.80 | $1.4K | 909,943 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-15 | 2026-05-15 | 200 | $13.95 | $2.8K | 910,143 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-13 | 2026-05-15 | 75,178 | $14.00 | $1.05M | 909,843 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-13 | 2026-05-15 | 4,081 | $13.80 | $56.3K | 834,665 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-12 | 2026-05-13 | 800 | $13.83 | $11.1K | 830,584 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-11 | 2026-05-13 | 19,900 | $14.00 | $278.6K | 829,784 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-11 | 2026-05-13 | 5,100 | $14.00 | $71.4K | 784,884 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-11 | 2026-05-13 | 25,000 | $14.00 | $350.0K | 809,884 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-05 | 2026-05-06 | 35,101 | $14.00 | $491.4K | 779,784 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-04 | 2026-05-06 | 116,904 | $13.97 | $1.63M | 744,683 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2026-05-04 | 2026-05-06 | 3,900 | $13.90 | $54.2K | 627,779 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 743,358 | $17.75 | $13.19M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 4,391,237 | $17.75 | $77.94M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 254,669 | $17.75 | $4.52M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise deriv | 2025-06-20 | 2025-06-24 | 2 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise deriv | 2025-06-20 | 2025-06-24 | 14 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise deriv | 2025-06-20 | 2025-06-24 | 1 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise | 2025-06-20 | 2025-06-24 | 200 | $70.00 | $14.0K | 743,358 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise | 2025-06-20 | 2025-06-24 | 100 | $60.00 | $6.0K | 4,392,637 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise | 2025-06-20 | 2025-06-24 | 1,400 | $70.00 | $98.0K | 4,391,237 | SEC↗ |
| KROS Keros Therapeutics, Inc. | E Expire deriv | 2025-05-16 | 2025-06-12 | 178 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | E Expire deriv | 2025-05-16 | 2025-06-12 | 300 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | E Expire deriv | 2025-05-16 | 2025-06-12 | 836 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | J Other deriv | 2025-04-09 | 2025-04-11 | 325,000 | — | $0 | 624,333 | SEC↗ |
| KROS Keros Therapeutics, Inc. | J Other deriv | 2025-04-09 | 2025-04-11 | 500,000 | — | $0 | 124,333 | SEC↗ |
| KROS Keros Therapeutics, Inc. | J Other deriv | 2025-04-09 | 2025-04-11 | 74,333 | — | $0 | 50,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 74,333 | $10.33 | $767.9K | 4,392,737 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 18,560 | $9.40 | $174.5K | 3,493,404 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 16,365 | $9.40 | $153.8K | 743,558 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 325,000 | $9.86 | $3.20M | 3,818,404 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 500,000 | $10.33 | $5.17M | 4,318,404 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2024-08-12 | 2024-08-12 | 2,243 | $15.88 | $35.6K | 129,574 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2024-08-12 | 2024-08-12 | 757 | $15.88 | $12.0K | 15,067 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2024-08-09 | 2024-08-12 | 3,000 | $14.89 | $44.7K | 127,331 | SEC↗ |